These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
453 related items for PubMed ID: 22208491
1. FMS-like tyrosine kinase 3 internal tandem duplication and the patterns of its gene sequence in 207 Chinese patients with de novo acute myeloid leukemia. Zhong L, Jia YQ, Meng WT, Ni X. Arch Pathol Lab Med; 2012 Jan; 136(1):84-9. PubMed ID: 22208491 [Abstract] [Full Text] [Related]
2. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation. Rausei-Mills V, Chang KL, Gaal KK, Weiss LM, Huang Q. Am J Clin Pathol; 2008 Apr; 129(4):624-9. PubMed ID: 18343790 [Abstract] [Full Text] [Related]
3. Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia. Liang DC, Shih LY, Hung IJ, Yang CP, Chen SH, Jaing TH, Liu HC, Chang WH. Cancer; 2002 Jun 15; 94(12):3292-8. PubMed ID: 12115363 [Abstract] [Full Text] [Related]
4. Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia. How J, Sykes J, Gupta V, Yee KW, Schimmer AD, Schuh AC, Minden MD, Kamel-Reid S, Brandwein JM. Cancer; 2012 Dec 15; 118(24):6110-7. PubMed ID: 22736495 [Abstract] [Full Text] [Related]
5. [Correlation of Fms-like tyrosine kinase 3 (FLT3) gene expression to FLT3/internal tandem duplication mutation in peripheral blood of acute myeloid leukemia.]. Xu B, Shi PC, Song XY, Tang JH, Zhou SY. Ai Zheng; 2009 Jun 15; 28(6):632-6. PubMed ID: 19635202 [Abstract] [Full Text] [Related]
6. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance]. Wang YG, Liu XH, Liang Y, Jin J. Zhonghua Xue Ye Xue Za Zhi; 2008 Nov 15; 29(11):741-5. PubMed ID: 19176010 [Abstract] [Full Text] [Related]
8. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance]. Wang J, Wang T, Li S, Lin L, Gang Y. Ai Zheng; 2007 Jan 15; 26(1):58-63. PubMed ID: 17222369 [Abstract] [Full Text] [Related]
9. Analysis of FLT3-ITD and FLT3-Asp835 mutations in de novo acute myeloid leukemia: evaluation of incidence, distribution pattern, correlation with cytogenetics and characterization of internal tandem duplication from Indian population. Ahmad F, Mandava S, Das BR. Cancer Invest; 2010 Jan 15; 28(1):63-73. PubMed ID: 19995225 [Abstract] [Full Text] [Related]
11. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome. Shih LY, Lin TL, Wang PN, Wu JH, Dunn P, Kuo MC, Huang CF. Cancer; 2004 Sep 01; 101(5):989-98. PubMed ID: 15329908 [Abstract] [Full Text] [Related]
12. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA. Jilani I, Estey E, Manshuri T, Caligiuri M, Keating M, Giles F, Thomas D, Kantarjian H, Albitar M. Leukemia; 2003 Jan 01; 17(1):114-9. PubMed ID: 12529667 [Abstract] [Full Text] [Related]
14. Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation. Jiang A, Jiang H, Brandwein J, Kamel-Reid S, Chang H. Leuk Res; 2011 Apr 01; 35(4):492-8. PubMed ID: 20684989 [Abstract] [Full Text] [Related]
15. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia. Dang H, Chen Y, Kamel-Reid S, Brandwein J, Chang H. Hum Pathol; 2013 Oct 01; 44(10):2038-46. PubMed ID: 23701943 [Abstract] [Full Text] [Related]
16. Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis. Brunet S, Labopin M, Esteve J, Cornelissen J, Socié G, Iori AP, Verdonck LF, Volin L, Gratwohl A, Sierra J, Mohty M, Rocha V. J Clin Oncol; 2012 Mar 01; 30(7):735-41. PubMed ID: 22291086 [Abstract] [Full Text] [Related]
18. Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia. Zhang W, Konopleva M, Shi YX, McQueen T, Harris D, Ling X, Estrov Z, Quintás-Cardama A, Small D, Cortes J, Andreeff M. J Natl Cancer Inst; 2008 Feb 06; 100(3):184-98. PubMed ID: 18230792 [Abstract] [Full Text] [Related]
19. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia. Scholl S, Theuer C, Scheble V, Kunert C, Heller A, Mügge LO, Fricke HJ, Höffken K, Wedding U. Eur J Haematol; 2008 Mar 06; 80(3):208-15. PubMed ID: 18081718 [Abstract] [Full Text] [Related]
20. [FLT3 mutations in children with acute myeloid leukemia: a single center study]. Ruan M, Wang YQ, Zhang L, Liu TF, Liu F, Liu XM, Zhang JY, Zou Y, Chen YM, Zhu XF. Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov 06; 13(11):863-6. PubMed ID: 22099191 [Abstract] [Full Text] [Related] Page: [Next] [New Search]